SURMODICS INC — Director's Dealing 2022

Nov 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2022-11-11

Reporting Person: KALICH RONALD B SR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-11	Common Stock	M	4366	$20.18	Acquired	32912	Direct
2022-11-11	Common Stock	S	2733	$33.4838	Disposed	30179	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-11	Stock Option (right to buy)	$20.18	M	4366	Disposed	2022-12-18	Common Stock (4366)	Direct

Footnotes

F1: Reflects the weighted average price of 2,733 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 11, 2022 with sale prices ranging from $33.40 to $33.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The amount beneficially owned includes 10,113 restricted stock units (RSUs) that vest on service-based vesting dates and 12,016 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.

F3: Fully vested.